Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-88,721
Closed -$14.8M 31
2016
Q3
$14.8M Buy
88,721
+67
+0.1% +$11.3K 0.45% 44
2016
Q2
$13.5M Sell
88,654
-15,493
-15% -$2.41M 0.41% 57
2016
Q1
$15.6M Sell
104,147
-4,672
-4% -$694K 0.47% 42
2015
Q4
$17.7M Sell
108,819
-3,035
-3% -$477K 0.55% 32
2015
Q3
$15.5M Buy
111,854
+7,793
+7% +$1.23M 0.48% 36
2015
Q2
$16M Sell
104,061
-9,789
-9% -$1.57M 0.48% 34
2015
Q1
$18.2M Sell
113,850
-11,931
-9% -$1.88M 0.51% 39
2014
Q4
$20M Sell
125,781
-5,555
-4% -$866K 0.58% 33
2014
Q3
$18.4M Sell
131,336
-178
-0.1% -$23.2K 0.55% 36
2014
Q2
$15.6M Sell
131,514
-4,602
-3% -$533K 0.48% 40
2014
Q1
$16.8M Sell
136,116
-5,739
-4% -$696K 0.53% 37
2013
Q4
$16.2M Sell
141,855
-766
-0.5% -$87.1K 0.5% 40
2013
Q3
$16M Sell
142,621
-16,815
-11% -$1.82M 0.56% 37
2013
Q2
$15.7M Buy
+159,436
New +$16.5M 0.55% 35

Other funds holding AMGN

Dai-ichi Life Holdings's AMGN Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Amgen (AMGN) in Q4 2016, closing a stake of 88,721 shares — an estimated $14.8M sold.

Dai-ichi Life Holdings first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $20M in Q4 2014. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 88,721 Amgen shares in Q4 2016, an estimated $14.8M.
  • Dai-ichi Life Holdings first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Amgen position peaked at $20M in Q4 2014.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.